Template:Ocular vascular disorder agents: Difference between revisions
Content deleted Content added
nav |
Bevacizumab - Avastin |
||
| Line 5: | Line 5: | ||
| group1 = Anti[[Choroidal neovascularization|neovascularisation]] agents |
| group1 = Anti[[Choroidal neovascularization|neovascularisation]] agents |
||
| list1 = [[Verteporfin]]{{•}} [[Anecortave]]{{•}} [[Pegaptanib]]{{•}} [[Ranibizumab]] |
| list1 = [[Verteporfin]]{{•}} [[Anecortave]]{{•}} [[Pegaptanib]]{{•}} [[Ranibizumab]]{{•}} [[Bevacizumab]] |
||
| belowstyle = background-color: LemonChiffon |
| belowstyle = background-color: LemonChiffon |
||